Company Overview and News

0
Mazda restarts auto plants in flood-hit parts of western Japan

2018-07-12 japantimes.co.jp
OSAKA – Mazda Motor Corp. resumed operations at its plants in western Japan on Thursday in the wake of devastating flooding and landslides.
7261 MZDAY MZDAF

2
Nikkei rises to 1-1/2-week high on Wall Street rally

2018-07-10 thehindubusinessline
Yahoo Japan Corp was up 10 per cent after rising as much as 11.66 per cent.
7261 MZHOF SMFG HCTHY ICLQY SFTBF SMFNF TOELY 8306 4689 532281 YAHOY TOELF MBFJF SFTBY ADTTF MZDAY 532822 YAHOF 8316 MZDAF HCLTECH IDEA MUFG 8411 9984 8035 ATEYY MTU MFG

0
Rescuers race to find survivors after Japan floods kill at least 114

2018-07-09 theedgemarkets
KURASHIKI, Japan (July 9): Rescuers in Japan dug through mud and rubble on Monday, racing to find survivors after torrential rain unleashed floods and landslides that killed at least 114 people, with dozens missing.
7261 MZDAY MZDAF

4
Nikkei rebounds to 1-week high after U.S. jobs data; Nissan tumbles

2018-07-09 reuters
TOKYO, July 9 (Reuters) - Japan’s Nikkei share average rebounded to one-week highs on Monday as investors took heart from U.S. jobs growth, while Eisai extended its gains to its daily-limit high on optimism for its Alzheimer’s drug.
7261 PCRFY MZDAY TTDKF BIIB 8306 MZDAF MUFG MBFJF MTU

4
Nikkei rebounds to 1-week high on US jobs data

2018-07-09 thehindubusinessline
Japan's Nikkei share average rebounded to a one-week high on Monday morning as investors took heart from US jobs growth, while Eisai extended its gains to its daily-limit high on optimism for its Alzheimer's drug.
7261 MZHOF PCRFY MZDAY TTDKF BIIB 8306 MZDAF MUFG 8411 MBFJF MTU MFG

4
Nikkei rebounds to 1-week high after U.S. jobs data; Eisai jumps

2018-07-09 reuters
TOKYO, July 9 (Reuters) - Japan’s Nikkei share average rebounded to one-week highs on Monday morning as investors took heart from U.S. jobs growth, while Eisai extended its gains to its daily-limit high on optimism for its Alzheimer’s drug.
7261 MZHOF PCRFY MZDAY TTDKF BIIB 8306 MZDAF MUFG 8411 MBFJF MTU MFG

0
At least 64 killed in Japan after 'unprecedented' rain, dozens missing - Channel NewsAsia

2018-07-08 channelnewsasia
TOKYO: The death toll from unprecedented rains in Japan rose to at least 64 on Sunday after rivers burst their banks and forced several million people from their homes, media reports said, with more rain set to hit some areas for at least another day.
7261 PCRFY MZDAY MZDAF

0
Death Toll Rises to 54 as `Historic' Floods Continue in Japan - Bloomberg

2018-07-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
7261 PCRFY MZDAY TM TYT TOYOF MMTOY MZDAF 9437 7203 NTDMF 7211 MMTOF DCM

0
Mazda halts production at Hiroshima plant as floods hit west Japan, 11 dead

2018-07-07 livemint
Tokyo: At least 11 people have died and thousands have fled their homes because of flooding in western Japan, with Mazda Motor Corp. in Hiroshima halting production at the weekend.
7261 MZDAY TM MZDAF 7203 TYT TOYOF

0
At least 49 killed, 48 missing as torrential rain pounds Japan

2018-07-07 channelnewsasia
TOKYO: Forty nine people have been killed and 48 are unaccounted for in western and central Japan as torrential rain pounds the area, public broadcaster NHK said on Saturday, with more than 1.6 million evacuated from their homes.
7261 MMTOY MZDAY MZDAF 7211 MMTOF

0
At least 27 killed, 47 missing as torrential rain pounds Japan - Channel NewsAsia

2018-07-07 channelnewsasia
TOKYO: At least 47 people were missing and five were in a critical condition as torrential rain that has killed 27 people pounds western and central Japan, public broadcaster NHK said on Saturday, with more than 1.6 million people evacuated from their homes.
7261 MMTOY MZDAY MZDAF 7211 MMTOF

0
Asia's Vulnerability to U.S. Car Tariffs in Five Easy Pieces - Bloomberg

2018-07-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
7261 MZDAY HYUO KIMTF TM MZDAF 7203 TYT HYUP KIMTY TOYOF HYUD

0
Donald Trump's import regulations slammed by GM, Ford and Fiat Chrysler

2018-07-03 nzherald.co.nz
Two words sum up how auto companies are portraying the future if the Trump administration determines that car imports are a national security threat and slaps imported vehicles and parts with tariffs: doom and gloom.
7261 MZDAY MZDAF

10
Subaru, Mazda are fine being last to sell electric cars

2018-06-30 livemint
Subaru owners are a green bunch. They tend to bike, camp and kayak more than other drivers and inordinately live in the parts of the US with the toughest emissions mandates. The company plays to this ecological image by producing more than 1 million vehicles each year without sending any waste to landfills. Yet the Subaru set can’t buy a battery-powered version of its favourite car.
7261 WKHS PCRFY BAMXY MZDAY BMWYY BYMOF BAMXF VLKAF GM.WS.A GM.WS.B MZDAF GM.WS.C GM GM.WSB

4
Mazda joins Toyota in condemning Trump's car-tariff plans

2018-06-29 theedgemarkets
(June 29): Mazda Motor Corp became the latest auto company to condemn the Trump administration’s plans for potential car import tariffs, saying such duties would hit both the industry, as well as U.S. consumers.
7261 MZDAY TM MZDAF 7203 TYT TOYOF

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...